-

Afinitor 10 mg tablets
- admission: Great Britain
- Producer: Novartis Europharm Ltd.
- ATC-Code: L01XE10
- Active Substance: Everolimus
-

Afinitor 5 mg tablets
- admission: Great Britain
- Producer: Novartis Europharm Ltd.
- ATC-Code: L01XE10
- Active Substance: Everolimus
-

AFLUNOV suspension for injection in pre-filled syringe. Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
- admission: Great Britain
- Producer: Novartis Vaccines and Diagnostics S.r.l.
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
- Active Substance: Influenza Virus Surface Antigens
-

Celvapan suspension for injection Influenza vaccine (H1N1)v (whole virion, Vero cell derived, inactivated)
- admission: Great Britain
- Producer: Baxter AG
- ATC-Code: J07BB01
- Therapeutic Area: Influenza
-

Daronrix, suspension for injection in multidose container Pandemic influenza vaccine (whole virion, inactivated, adjuvanted)
- admission: Great Britain
- Producer: GlaxoSmithKline Biologicals S.A.
- ATC-Code: J07BB01
- Therapeutic Area: Influenza
-

Daronrix, suspension for injection in pre-filled syringe Pandemic influenza vaccine (whole virion, inactivated, adjuvanted)
- admission: Great Britain
- Producer: GlaxoSmithKline Biologicals S.A.
- ATC-Code: J07BB01
- Therapeutic Area: Influenza
-

Daronrix, suspension for injection. Pandemic influenza vaccine (whole virion, inactivated, adjuvanted)
- admission: Great Britain
- Producer: GlaxoSmithKline Biologicals S.A.
- ATC-Code: J07BB01
- Therapeutic Area: Influenza
-

FLUENZ nasal spray suspension Influenza vaccine (live attenuated, nasal)
- admission: Great Britain
- Producer: MedImmune LLC
- ATC-Code: J07BB03
- Therapeutic Area: Influenza
-

Focetria suspension for injection in multidose container Influenza vaccine H1N1v (surface antigen, inactivated, adjuvanted)
- admission: Great Britain
- Producer: Novartis Vaccines and Diagnostics S.r.l.
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
- Active Substance: Influenza Virus Surface Antigens
-

Focetria suspension for injection in pre-filled syringe Influenza vaccine H1N1v (surface antigen, inactivated, adjuvanted)
- admission: Great Britain
- Producer: Novartis Vaccines and Diagnostics S.r.l.
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
- Active Substance: Influenza Virus Surface Antigens
-

Foclivia suspension for injection Pandemic influenza vaccine (surface antigen, inactivated, adjuvanted)
- admission: Great Britain
- Producer: Novartis Vaccines and Diagnostics S.r.l.
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
- Active Substance: Influenza Virus Surface Antigens
-

Foclivia suspension for injection in multidose container Pandemic influenza vaccine (surface antigen, inactivated, adjuvanted)
- admission: Great Britain
- Producer: Novartis Vaccines and Diagnostics S.r.l.
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
- Active Substance: Influenza Virus Surface Antigens
-

Foclivia suspension for injection in pre-filled syringe Pandemic influenza vaccine (surface antigen, inactivated, adjuvanted)
- admission: Great Britain
- Producer: Novartis Vaccines and Diagnostics S.r.l.
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
- Active Substance: Influenza Virus Surface Antigens
-

IDflu 15 microgram/strain suspension for injection Influenza vaccine (split virion, inactivated)
- admission: Great Britain
- Producer: Sanofi Pasteur S.A.
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
-

IDflu 9 microgram/strain suspension for injection Influenza vaccine (split virion, inactivated)
- admission: Great Britain
- Producer: Sanofi Pasteur S.A.
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
-

INTANZA 15 microgram/strain suspension for injection Influenza vaccine (split virion, inactivated)
- admission: Great Britain
- Producer: Sanofi Pasteur MSD, SNC
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
-

INTANZA 9 microgram/strain suspension for injection Influenza vaccine (split virion, inactivated)
- admission: Great Britain
- Producer: Sanofi Pasteur MSD, SNC
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
-

Optaflususpension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures)(2007/2008 season)
- admission: Great Britain
- Producer: Novartis Vaccines and Diagnostics GmbH & Co. KG
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
- Active Substance: Influenza Virus Surface Antigens
-

Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals, suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)
- admission: Great Britain
- Producer: GlaxoSmithKline Biologicals S.A.
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
-

PANDEMIC INFLUENZA VACCINE H5N1 BAXTER Suspension for injection Pandemic influenza vaccine (whole virion, Vero cell derived, inactivated)
- admission: Great Britain
- Producer: Baxter AG
- ATC-Code: J07BB01
- Therapeutic Area: Influenza
-

Pandemrix suspension and emulsion for emulsion for injection. Influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted)
- admission: Great Britain
- Producer: GlaxoSmithKline Biologicals S.A.
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
-

Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg suspension and emulsion for emulsion for injection. Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)
- admission: Great Britain
- Producer: GlaxoSmithKline Biologicals S.A.
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
-

Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics suspension for injection in pre-filled syringe. Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
- admission: Great Britain
- Producer: Novartis Vaccines and Diagnostics S.r.l.
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
- Active Substance: Influenza Virus Surface Antigens
-

Prepandrix suspension and emulsion for emulsion for injection. Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)
- admission: Great Britain
- Producer: GlaxoSmithKline Biologicals S.A.
- ATC-Code: J07BB02
- Therapeutic Area: Influenza
-

SYNAGIS 100 mg powder and solvent for solution for injection
- admission: Great Britain
- Producer: Abbott Laboratories Ltd.
- ATC-Code: J06BB16
-

SYNAGIS 50 mg powder and solvent for solution for injection
- admission: Great Britain
- Producer: Abbott Laboratories Ltd.
- ATC-Code: J06BB16